{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T21:39:53Z","timestamp":1782077993793,"version":"3.54.5"},"reference-count":63,"publisher":"Royal College of General Practitioners","issue":"758","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Gen Pract"],"accepted":{"date-parts":[[2025,5,9]]},"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acne is a common, chronic, and burdensome disease. There is evidence of delayed and inequitable patient access to isotretinoin. Overuse of antibiotics in patients with acne raises antimicrobial stewardship concerns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To identify clinical practice guideline (CPG) and consensus statement recommendations regarding the clinical competencies required for prescribing oral isotretinoin for acne.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and setting<\/jats:title>\n                    <jats:p>This was a scoping review of acne CPGs and consensus statements, globally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>The Arksey and O\u2019Malley framework informed design in conjunction with Joanna Briggs Institute guidance. The PRISMA extension for Scoping Reviews guided reporting. The search was conducted across six databases (Embase, Scopus, Web of Science, PubMed, CINAHL, PsycINFO), three guideline repositories (Scottish Intercollegiate Guidelines Network, Guidelines International Network, Trip), and grey literature. Two researchers independently screened titles and abstracts, and full-text papers. The AGREE II checklist appraised CPG quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From the initial 2292 articles, eight CPGs were included after applying inclusion and exclusion criteria. Five were from Europe, with one each from the US, Canada, and Malaysia. The CPG guidance varied regarding 'Which doctor may prescribe isotretinoin?' All CPGs indicated dermatologists and four identified GPs as appropriate prescribers. The CPGs identify the clinical competencies to safely manage people with acne using isotretinoin: dermatology, pregnancy prevention, mental health assessment, and blood testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This scoping review has identified the key clinical competencies that underpin safe management of people with acne using isotretinoin: dermatology, pregnancy prevention, mental health assessment, and blood testing. Resourcing and supporting GPs to incrementally adopt this role may promote safe, timely, and equitable patient access to isotretinoin, while enhancing antimicrobial stewardship.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3399\/bjgp.2025.0135","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T07:15:19Z","timestamp":1750835719000},"page":"e597-e606","source":"Crossref","is-referenced-by-count":4,"title":["Competencies and clinical guidelines for managing acne with isotretinoin in general practice: a scoping review"],"prefix":"10.3399","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7542-6028","authenticated-orcid":false,"given":"Diarmuid","family":"Quinlan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7496-9477","authenticated-orcid":false,"given":"Laura","family":"Sahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0003-0774","authenticated-orcid":false,"given":"Linda","family":"O\u2019Keeffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7264-5260","authenticated-orcid":false,"given":"Miriam","family":"Santer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0473-3319","authenticated-orcid":false,"given":"Alison M","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3205-3871","authenticated-orcid":false,"given":"Tony","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1987","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"2025102901501352000_75.758.e597.1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20882"},{"key":"2025102901501352000_75.758.e597.2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12149"},{"key":"2025102901501352000_75.758.e597.3","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.446"},{"key":"2025102901501352000_75.758.e597.4","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19477"},{"key":"2025102901501352000_75.758.e597.5","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.4818"},{"issue":"1346","key":"2025102901501352000_75.758.e597.6","first-page":"34","article-title":"Usage and equity of access to isotretinoin in new zealand by deprivation and ethnicity","volume":"124","author":"Moodie","year":"2011","journal-title":"N Z Med J"},{"key":"2025102901501352000_75.758.e597.7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210445"},{"key":"2025102901501352000_75.758.e597.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.12.043"},{"key":"2025102901501352000_75.758.e597.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00527-7"},{"key":"2025102901501352000_75.758.e597.10","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16686"},{"key":"2025102901501352000_75.758.e597.11","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15129"},{"key":"2025102901501352000_75.758.e597.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.09.024"},{"key":"2025102901501352000_75.758.e597.13","doi-asserted-by":"publisher","DOI":"10.4161\/derm.1.3.9364"},{"key":"2025102901501352000_75.758.e597.14","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2995"},{"key":"2025102901501352000_75.758.e597.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.12.017"},{"key":"2025102901501352000_75.758.e597.16","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.140665"},{"key":"2025102901501352000_75.758.e597.17","unstructured":"Malaysian Health Technology Assessment Section (MaHTAS) (2022) Clinical practice guidelines: management of acne vulgaris. 2nd edn (MaHTAS), accessed. https:\/\/www.moh.gov.my\/moh\/resources\/Penerbitan\/CPG\/Skin%20Condition\/e-CPG_Ance-26_11_22.pdf. 23 Jul 2025."},{"key":"2025102901501352000_75.758.e597.18","unstructured":"Nederlands Huisartsen Genootschap (NHG) Group (2017) Acne. NHG Guidelines (NHG), accessed. https:\/\/richtlijnen.nhg.org\/standaarden\/acne. 23 Jul 2025."},{"key":"2025102901501352000_75.758.e597.19","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13776"},{"key":"2025102901501352000_75.758.e597.20","unstructured":"National Institute for Health and Care Excellence (NICE) (2021) Overview. Acne vulgaris: management. Guidance NG198 (NICE), accessed. https:\/\/www.nice.org.uk\/guidance\/ng198. 23 Jul 2025."},{"key":"2025102901501352000_75.758.e597.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)80252-6"},{"key":"2025102901501352000_75.758.e597.22","doi-asserted-by":"publisher","DOI":"10.1159\/000246015"},{"key":"2025102901501352000_75.758.e597.23","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200102030-00002"},{"key":"2025102901501352000_75.758.e597.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.02.040"},{"key":"2025102901501352000_75.758.e597.25","unstructured":"Commission on Human Medicines (2023) Report of the Commission on Human Medicines Isotretinoin Expert Working Group (Commission on Human Medicines), accessed. https:\/\/assets.publishing.service.gov.uk\/media\/6448cd0a529eda00123b047d\/Isotretinoin-final-CHM-report-26April2023.pdf. 23 Jul 2025."},{"key":"2025102901501352000_75.758.e597.26","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.20373"},{"key":"2025102901501352000_75.758.e597.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09976.x"},{"key":"2025102901501352000_75.758.e597.28","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14294"},{"key":"2025102901501352000_75.758.e597.29","doi-asserted-by":"publisher","DOI":"10.1177\/20420986241272822"},{"key":"2025102901501352000_75.758.e597.30","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-023-00381-3"},{"key":"2025102901501352000_75.758.e597.31","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13950"},{"key":"2025102901501352000_75.758.e597.32","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.0189"},{"key":"2025102901501352000_75.758.e597.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.06.025"},{"key":"2025102901501352000_75.758.e597.34","unstructured":"Commission on Human Medicines (2023) Report of The Commission on Human Medicines Isotretinoin Implementation Advisory Expert Working Group: independent report (Commission on Human Medicines), accessed. https:\/\/assets.publishing.service.gov.uk\/media\/653fd71946532b001467f58b\/IIAEWGreport.pdf. 24 Jul 2025."},{"key":"2025102901501352000_75.758.e597.35","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llae168"},{"key":"2025102901501352000_75.758.e597.36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021549"},{"key":"2025102901501352000_75.758.e597.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadr.2021.100230"},{"key":"2025102901501352000_75.758.e597.38","unstructured":"Australasian College of Dermatologists (2024) Position statement: isotretinoin for the treatment of acne (Australasian College of Dermatologists), accessed. https:\/\/www.dermcoll.edu.au\/wp-content\/uploads\/2024\/11\/Isotretinoin-Position-Statement_202410.pdf. 24 Jul 2025."},{"key":"2025102901501352000_75.758.e597.39","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.4579"},{"key":"2025102901501352000_75.758.e597.40","unstructured":"Best Practice Advocacy Centre New Zealand (BPACNZ) (2013) Managing acne in primary care (BPACNZ), accessed. https:\/\/bpac.org.nz\/BPJ\/2013\/March\/managing-acne.aspx#4. 24 Jul 2025."},{"key":"2025102901501352000_75.758.e597.41","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.3270"},{"key":"2025102901501352000_75.758.e597.42","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp20X712337"},{"key":"2025102901501352000_75.758.e597.43","doi-asserted-by":"crossref","unstructured":"Graham R Mancher M Miller Wolman D (2011) Clinical practice guidelines we can trust (National Academies Press, Washington, DC).","DOI":"10.17226\/13058"},{"key":"2025102901501352000_75.758.e597.44","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92244-N"},{"key":"2025102901501352000_75.758.e597.45","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16430"},{"key":"2025102901501352000_75.758.e597.46","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.240"},{"key":"2025102901501352000_75.758.e597.47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01200.x"},{"key":"2025102901501352000_75.758.e597.48","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/893080"},{"key":"2025102901501352000_75.758.e597.49","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15843"},{"key":"2025102901501352000_75.758.e597.50","doi-asserted-by":"publisher","DOI":"10.1080\/1364557032000119616"},{"key":"2025102901501352000_75.758.e597.51","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-21-00242"},{"key":"2025102901501352000_75.758.e597.52","doi-asserted-by":"crossref","unstructured":"Quinlan D Foley T Sahm L (2024) OSF Registries, The role of general practitioners in the management of patients with severe acne using isotretinoin in Clinical Practice Guidance: a scoping review protocol. accessed. https:\/\/osf.io\/yd42v. 30 Jul 2025.","DOI":"10.12688\/hrbopenres.13914.1"},{"key":"2025102901501352000_75.758.e597.53","doi-asserted-by":"publisher","DOI":"10.12688\/hrbopenres.13914.1"},{"key":"2025102901501352000_75.758.e597.54","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-9-3"},{"key":"2025102901501352000_75.758.e597.55","unstructured":"(2025) (EQuiP). https:\/\/www.qualityfamilymedicine.eu\/page\/about-equip."},{"key":"2025102901501352000_75.758.e597.56","unstructured":"(2025) Better systematic review management (Covidence), accessed. https:\/\/www.covidence.org\/. 24 Jul 2025."},{"key":"2025102901501352000_75.758.e597.57","unstructured":"AGREE Next Steps Consortium (2017) Appraisal of guidelines for research & evaluation II (AGREE Next Steps Consortium), accessed. https:\/\/www.agreetrust.org\/wp-content\/uploads\/2017\/12\/AGREE-II-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf. 24 Jul 2025."},{"key":"2025102901501352000_75.758.e597.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.12.009"},{"key":"2025102901501352000_75.758.e597.59","unstructured":"JBI Global Wiki Chapter 11: scoping reviews \u2014 JBI manual for evidence synthesis. https:\/\/jbi-global-wiki.refined.site\/space\/MANUAL\/4687342\/Chapter+11%3A+Scoping+reviews."},{"key":"2025102901501352000_75.758.e597.60","unstructured":"(2017) (Worel). https:\/\/www.worel.be\/worel\/document?parameters=%7B%22PublicationId%22%3A%229294ADAA-305A-4699-93D1-A76000CABAA6%22%7D."},{"key":"2025102901501352000_75.758.e597.61","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-093572"},{"key":"2025102901501352000_75.758.e597.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.07.001"},{"key":"2025102901501352000_75.758.e597.63","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp17X689929"}],"container-title":["British Journal of General Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/BJGP.2025.0135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T08:55:16Z","timestamp":1761728116000},"score":1,"resource":{"primary":{"URL":"http:\/\/bjgp.org\/lookup\/doi\/10.3399\/BJGP.2025.0135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":63,"journal-issue":{"issue":"758","published-online":{"date-parts":[[2025,8,28]]},"published-print":{"date-parts":[[2025,9,1]]}},"alternative-id":["10.3399\/BJGP.2025.0135"],"URL":"https:\/\/doi.org\/10.3399\/bjgp.2025.0135","relation":{},"ISSN":["0960-1643","1478-5242"],"issn-type":[{"value":"0960-1643","type":"print"},{"value":"1478-5242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}